—NUE
— • —
$186.12
P/E
24.61
PEG
—
FCF Yield
—
Rev Growth YoY
+573.0% YoY
Gross Margin
1193.0%
Health Score
5/10
D/E Ratio
0.34
Confidence
LOW
Business Snapshot
The ticker and company identity fields are unpopulated in this data payload, which limits contextual framing. Based on the available financial profile — a current price of $186.12, a P/E of 24.61x, and a Price/Sales of 1.32x — this appears to be an operating company with meaningful revenue scale. Without a confirmed market cap figure, cap tier classification cannot be made with certainty, though the valuation ratios suggest a company of at least mid-scale operations.
Financial Health
**Score: 5/10** The balance sheet shows a conservative debt posture with a Debt/Equity ratio of 0.34x, and liquidity appears solid with a Current Ratio of 2.94x — meaning the company holds nearly $3 in current assets for every $1 of short-term liabilities. However, Free Cash Flow is unavailable, which is a significant gap: without FCF data, it is impossible to confirm whether reported profits are converting to real cash, making this score provisional...
Risk Assessment
- **DATA INTEGRITY:** Gross margin of 1,193% and net margin of 537% are implausible for virtually any business and suggest a data normalisation or reporting anomaly that cannot be reconciled from this payload. - **EARNINGS DETERIORATION:** Earnings growth of -1,095% YoY directly contradicts the 573% revenue surge, signalling a severe disconnect between top-line growth and profitability. - **CASH FLOW OPACITY:** Free Cash Flow is unavailable, making it impossible to confirm whether earnings or revenue figures translate into real liquidity. - **TECHNICAL WEAKNESS:** A confirmed death cross (50-day MA crossing below 200-day MA) alongside a bearish MACD signal suggests the prevailing price trend is negative. - **IDENTITY UNCERTAINTY:** The ticker, exchange, sector, and industry fields are all unpopulated, which limits the ability to benchmark any metric against a relevant peer group or sector average. ---...